Navigation Links
Cancer and arthritis therapy may be promising treatment for diabetes
Date:12/18/2007

New Haven, Conn.An antibody used to treat certain cancers and rheumatoid arthritis appears to greatly delay type 1 diabetes in mice, Yale School of Medicine researchers report in the Journal of Clinical Investigation.

Even better, the beneficial effects of the antibody continue to be observed long after the antibody is no longer administered, the researchers said.

The antibody, rituximab (anti-CD20), depletes B cells. Experimental evidence in mutant mice indicates that B cells play a role in autoimmune diseases by interacting with T cells of the immune system. It is T cells that destroy insulin-producing cells directly in the pancreas, leading to type 1 diabetes.

Our paper shows, for the first time, that after successful B cell depletion, regulatory cells emerge that can continue to suppress the inflammatory and autoimmune response even after the B cells return, said Li Wen, senior research scientist in the division of endocrinology. Even more strikingly, we found that these regulatory cells include both B and T cells.

To determine if B cell depletion would work as a therapy for type 1 diabetes, Wen and her colleague at Yale, Mark Shlomchik, M.D., professor of laboratory medicine and immunobiology, developed a mouse model. They engineered mice that were predisposed to diabetes and had the human version of CD20, the molecule rituximab targets, on the surface of their B cells.

The researchers tested a mouse version of the drug to deplete B cells in mice either before diabetes onset, or within days of diagnosis with diabetes. The drug treatment significantly delayed diabetes onset in pre-diabetic mice. This translated to a 10- to 15-week delay in developing diabetes compared to mice given a sham treatment. The equivalent period for humans would be approximately 10 to 15 years. Of the 14 mice that already had diabetes, five stopped needing insulin for two to five months while all the sham-treated mice remained dia
'/>"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. ESF EURYI award winner aims to stop cancer cells reading their own DNA
4. Protein chatter linked to cancer activation
5. Newly created cancer stem cells could aid breast cancer research
6. Western diet linked to increased risk of colon cancer recurrence
7. Obesity and lack of exercise could enhance the risk of pancreatic cancer
8. Low levels of key protein may indicate pancreatic cancer risk
9. Birth records hold pancreatic cancer clue
10. Many parents at-risk for cancer disclose genetic test results to children
11. A new radiation therapy treatment developed for head and neck cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/15/2008)...nge has long been a concern for environmental scie...e problem of excessive reactive nitrogen in the en...of environmental scientists who study how the elem...alters local and global ecosystems and potentially... environmental scientists bring the problem to the...
(Date:5/15/2008)...s has developed a simple artificial cell with whic...two of the most basic cell components: the cell me...t surrounds the structures in living cells. The w...ake advantage of properties of cell organization t... findings will be published later this month (late...
(Date:5/15/2008)...hether bacteria stick to surfaces depends partly o... created ultrathin films made of polymers that cou...s to control microbe accumulation. , The inexpen...le layer of protection for the health care industr...ired infections, which take the lives of 100,000 p...
(Date:5/15/2008)...nitrogen compounds emitted into the atmosphere by ... use of nitrogen fertilizers enters the oceans and...om the atmosphere, concluded a team of internation...ished Professor of Oceanography and Atmospheric Sc...m institutions around the world presented its conc...
Breaking Biology News(10 mins):Addressing the 'nitrogen cascade' 2Addressing the 'nitrogen cascade' 3Simple model cell is key to understanding cell complexity 2MIT crafts bacteria-resistant films 2MIT crafts bacteria-resistant films 3Atmosphere threatened by pollutants entering ocean, prof says 2Atmosphere threatened by pollutants entering ocean, prof says 3Three Chemo Drugs Better Than Two for Advanced Head Neck Cancers 4532 1Three Chemo Drugs Better Than Two for Advanced Head Neck Cancers 4532 2Three Chemo Drugs Better Than Two for Advanced Head Neck Cancers 4532 3Epilepsy drugs may cause sexual disorders 4529 1Gauging parent knowledge about teens substance use 4526 1Gauging parent knowledge about teens substance use 4526 2Gauging parent knowledge about teens substance use 4526 3Severely restricted diet linked to physical fitness into old age 956 1Severely restricted diet linked to physical fitness into old age 956 2
...ultural Experiment Station scientists will soon be...ed to protect crops, which has implications for bo... The fungus, Trichoderma virens, is used to protec...hers say the genome sequencing work may uncover ch...oducing new human and animal antibiotics. , The se...
..."superbugs" that defy current treatments has incre...ng the issue of antibiotic resistance. A new book ...rial Resistance is Undermining the Antibiotic Mira...in a reader-friendly, comprehensible style that wi...izens. , "Most people have a love-hate relationshi...
...e scientists have created the first active vaccine... the onset of a brain disease in mice that is simi...d online this week in the journal Neuroscience, co...ccine to prevent a group of fatal brain diseases c...s. , Although no cure for these diseases -- which ...
...iversity of Iowa Roy J. and Lucille A. Carver Coll...otential treatment for Huntington,s disease (HD). ...the scientists reduced levels of the disease-causi...he movement and neurological abnormalities normall... inherited, neurodegenerative disease that is prog...
Other Biology News:Experiment station researchers to explore genome of disease-fighting fungus 2New book explains antibiotic resistance for a broad audience 2Active Vaccine Prevents Mice From Developing Prion Disease 2Active Vaccine Prevents Mice From Developing Prion Disease 3U. Iowa researchers improve Huntington's disease symptoms in mice 2U. Iowa researchers improve Huntington's disease symptoms in mice 3
(Date:5/16/2008)...onsors Program to Recognize Exemplary Work ...IA, May 16 /- CURE magazine announced...y Healer Award for Oncology Nursing,during a recep...Annual,Congress. Ortho Biotech Products, L. P. spo... demonstrate unwavering dedication, compassion and...
(Date:5/16/2008).../- Senesco,Technologies, In...y reported,financial results for the three months ...th period ended March 31, 2008 was $2.0,million, o...8 million, or,$0.05 per share, for the three month... loss was primarily the result of an increase of $...
(Date:5/16/2008)...FirstCall/ - Oncolytics Biotech Inc. (TSX:,ONC, NA...ing interim,results of a Phase II study of intrave...tic to the lung is available on the American Socie...www.asco.org and on the Oncolytics,website at ht...ntitled "A Phase II,Study of Intravenous REOLYSIN ...
(Date:5/16/2008)... /- Arpida Ltd.,(SWX: ARPN)...istration,(FDA) has accepted for review the New Dr...he treatment of complicated Skin and Skin,Structur...ion of the NDA to,the agency in March 2008. FDA ha...prim NDA and has established the Prescription Drug...
Breaking Biology Technology:CURE Magazine Announces Winner of 2008 Extraordinary Healer Award 2Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 2Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 3Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 4Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 5Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 6Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 7Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results 8Oncolytics Biotech Inc. Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting 2Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 2Arpida Announces FDA Acceptance of the Iclaprim New Drug Application 3
... Information Networks , a provider of IT solutions... Midwest Region Partner Excellence" awards from M...d an award to recognize its customer satisfaction ...rprise Project Management (EPM) solution. Its offi...ompetency for its SharePoint portal solution, deve...
...vious editorials, presentations at national confer...tions that have acquired enterprise security packa...s. , ,Some have found out very quickly that inform...ectual property and other confidential material ca...eople give up secure information in many other way...
... automated anti-money laundering application capab... transactions is helping banks comply with federal...ove to support clients working to comply with regu...ot Act and the Bank Secrecy Act (BSA), the Milwau...y subsidiary of Marshall & Ilsley Corp , recently...
...owing body of university research under developmen...sin-Madison could grow at an even faster pace as ...day by University of Wisconsin System presidents a...The grant will provide funding over a four-year pe...us, however, extends beyond the length of the gran...
Other Biology Technology:Security goes beyond technology into common-sense practices 2Security goes beyond technology into common-sense practices 3Security goes beyond technology into common-sense practices 4Metavante application aimed at compliance 2WiSys to distribute $1 million in research funds 2WiSys to distribute $1 million in research funds 3WiSys to distribute $1 million in research funds 4
...a direct antibiotic-based selection system for rec...ends solely on colony survival, eliminating the ne...pensive process provides close to 100% accuracy in...al platform for robot colony picking. This cloning...
Mouse monoclonal [H4B4] to LAMP2 - Lysosome Marker (Phycoerythrin) ( Abpromise for all tested applications). entrezGeneID: 3920 SwissProtID: P13473
...ple thermal cycler is a dual-bay expansion for the...y, using a PC. The Dyad Disciple accommodates a va...r, heat-pump assemblies), which hold different typ...tor. Peltier heat pumps provide exceptional therma...
...kirted PCR plate, Directly compatible with ABI the...t deck for improved sealing characteristics can b...cap strips, Certified free of DNase, RNase and hum...ific, the world leader in serving science. Thermo ...
Biology Products: